Executive Leadership Team

Mr. Scott Myers has more than 20 years of experience in the pharmaceutical and health care consulting industries. This includes extensive experience from Europe and US in the areas of marketing, sales, business development and market access. Before joining Aerocrine,  Scott was part of UCB, a €3.0 billion global biopharmaceutical company where most recently he held the position of VP, Head of European Mid-Markets. In this role, Scott had overall responsibility for a region with a €400 million turnover that covered more than 30 countries and employed over 600 people. Under Scott’s leadership, group operating profit increased significantly and he led the launches of several small molecule and biologics, including Innovair for asthma.

Prior to UCB, Scott held several senior positions at Johnson & Johnson including Senior Vice President and General Manager of McNeil Specialty Products. In that position, Scott led a group of over 700 people and had overall responsibility for the $800 million pharmaceutical portfolio. Aerocrine shareholding : 0

Mats Carlson VP Development & Technical Operations

Mr Carlson was born in 1953 and has been a member of Aerocrine’s management since 1998. He has over 20 years’ product development and production experience in pharmaceuticals and medical technology. Mats is also a deputy Board member of RegMan AB. He was a Board member of the Swedish Industrial Design Foundation, SEDOC PM AB and the Karolinska Institute’s biotechnology Ph.D. program focusing on industry. His previous experience includes CEO of Pharmacia Chiron Partnership, a consultant for Wenell Management AB, Project Co-ordinator at Pharmacia and Project Manager at Siemens-Elema in product development for intensive care.
Aerocrine shareholding: 3,000 and warrants corresponding to 160,000 shares.

Michael Colérus Chief Financial Officer

Michael Colérus has a professional background in Pharmacia & Upjohn where he was Business Controller for several business areas. Michael was born in 1962, and has been Aerocrine’s CFO since 1999.
Aerocrine shareholding: 5,300 and warrants corresponding to 30,000 shares.

Morten Gunvad VP Commercial Operations Europe and Asia

Morten Gunvad has a broad international background in sales & marketing within medical devices. He was born in 1967 and was appoined VP Commercial Operations Europe & Asia for Aerocrine in 2011.  He was previously VP Soft Tissue Implants Europe for Covidien AG, Switzerland and a member of the European leadership team.  He was also Area Director for the Nordic region for Tyco Healthcare Norden, Area Sales Director for Tyco Healthcare Germany and several other positions within Tyco Healthcare and Auto Suture/United States Surgical Corporation.

Chip Neff President Aerocrine Inc.

Chip Neff has over 20 years experience in global sales, marketing and business development in the medical diagnostic business.  He was born in 1962 and was appointed as Aerocrine, Inc. President in February of 2008.  He previously worked for Quest Diagnostics Incorporated where he was responsible for North American Sales/Marketing for their HemoCue point-of-care testing business.  Before the successful acquisition of HemoCue AB by Quest Diagnostics, he worked for HemoCue AB for 12 years where he held a number of senior management positions. He holds as BS in Economics from Denison University in Ohio.  

Kathleen Rickard Chief Medical Officer

Kathleen Rickard is a Medical Doctor and specialist in Pulmonary and Critical Care Medicine.   She brings fifteen years of industry experience from senior leadership of respiratory medicines development at GlaxoSmithKline in the U.S.  Most recently, Dr. Rickard has served as Medical Director at PPD, a leading global contract research organization providing drug discovery, development and lifecycle management services.